Gansu Longshen Rongfa Pharmaceutical Co., Ltd. announced that its flagship product, Yuanhu Zhitong Dripping Pills, has received the Chinese Patent Medicine Registration Certificate approved and issued by the Pharmaceutical Administration Bureau of the Macao Special Administrative Region Government. The registration number is MAC-C00613, the category is over-the-counter Chinese patent medicine, and the registration holder is Tak Seng Tong Pharmaceutical Products Import, Export and Wholesale Firm. Yuanhu Zhitong Dripping Pills are a classic Chinese patent medicine included in the National Pharmacopoeia and are an exclusive product nationwide. Their functions are to regulate qi, promote blood circulation, and relieve pain, and they are used for menstrual abdominal pain, stomach pain, hypochondriac pain, and headache. They are a non-addictive pure Chinese herbal analgesic. The company stated that this approval marks its qualification to sell the drug in Macao, which is conducive to expanding overseas market business and enhancing brand and market competitiveness. However, it is not expected to have a significant impact on recent operating performance, and the company reminded that there are uncertainties in drug production and sales.
Gansu Longshenrongfa Pharmaceutical Industry Co LtdYuanhu Zhitong Dripping Pills received Macao registration certificate, granting qualification to sell the drug in Macao and expand overseas business.
